Paul Walter Schön

Learn More
Drug Utilization Research and Pharmacoepidemiology Meeting U t r e c h t ( T h e N e t h e r l a n d s ) , 19 M a y 1995 Organized by the Section of Drug Utilization and Pharmacoepidemiology of the Dutch Society of Pharmaceutical Sciences (Sectie Geneesmiddelengebruiksonderzoek en Farmacoepidemiologie van de Nederlandse Vereniging voor Farmaceutische(More)
This paper presents an original method for risk assessment in water treatment, based on belief functions. The risk of producing non-compliant drinking water (i.e., such that one of the quality parameter exceeds the regulation standards), is estimated taking into account the quality parameters of raw water and the process line of the treatment plant(More)
A methodology is proposed for assessing the risk to produce non-compliant potable water, taking into account the quality of the raw water, as well as characteristics of the treatment unit and different failure modes. Belief functions are used to describe expert knowledge of treatment process efficiency, failure rates, latency times and raw water quality.(More)
Bone metastases in patients with solid tumours (ST) and bone lesions in patients with haematological malignancies (HM) are common. Associated skeletal-related events (SREs) cause severe pain, reduced quality of life and place a burden on health care resources. Bone-targeted agents can reduce the risk of SREs. We evaluated the management of bone(More)
With increasing number of therapies available for the treatment of multiple myeloma, it is timely to examine the course of patients' journeys. We investigated patient characteristics, treatment durations and outcomes, and symptom burden across the treatment pathway in Belgium, France, Germany, Italy, Spain, Switzerland and the UK. In total, 435 physicians(More)
Real-world data describing management of patients with multiple myeloma are limited. A European (Belgium, France, Germany, Italy, Spain, Switzerland, UK) observational chart review was conducted to address this. Physicians completed questionnaires for every patient seen during a 2-4-week observation period, regardless of treatment status. A total of 435(More)
  • 1